Holen Sie sich die Stockscreener-App
0.00
100.00%
-4.36
Schlusskurs vom Vortag:
$4.36
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$96.26M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-94.11M
KGV:
0.00
EPS:
-6.01
Netto-Cashflow:
$-86.06M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$5.75
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
Firmenname
Adverum Biotechnologies Inc
Sektor
Branche
Telefon
(650) 649-1004
Adresse
100 CARDINAL WAY, REDWOOD CITY, CA
Compare ADVM vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
0.00 | 96.26M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
499.17 | 117.08B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
772.03 | 82.63B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
742.79 | 45.82B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.38 | 42.92B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
305.39 | 33.54B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-07 | Hochstufung | Truist | Hold → Buy |
| 2021-07-23 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | Herabstufung | Truist | Buy → Hold |
| 2020-12-16 | Eingeleitet | UBS | Neutral |
| 2020-11-12 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-05-05 | Hochstufung | SunTrust | Hold → Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-16 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-10 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | Bestätigt | Chardan Capital Markets | Neutral |
| 2019-09-13 | Bestätigt | Chardan Capital Markets | Neutral |
| 2019-06-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-11-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | Herabstufung | SunTrust | Buy → Hold |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-08-30 | Eingeleitet | SunTrust | Buy |
| 2018-02-15 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-10-12 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Adverum Biotechnologies Inc Aktie (ADVM) Neueste Nachrichten
Adverum Biotechnologies (ADVM) Price Target Decreased by 42.56% to 11.42 - MSN
Entry Recap: Should I hold or sell Adverum Biotechnologies Inc nowMarket Movers & Expert Approved Trade Ideas - baoquankhu1.vn
S P Trends: Should I average down on Adverum Biotechnologies Inc stockWeekly Earnings Recap & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Take Profit: Is Adverum Biotechnologies Inc part of any ETF2025 Earnings Impact & Growth Oriented Trading Recommendations - baoquankhu1.vn
USA Herald - USA Herald
ADVM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Pullback Watch: How do insiders feel about Adverum Biotechnologies IncWeekly Market Outlook & Entry Point Strategy Guides - baoquankhu1.vn
AI Stocks: Should I hold or sell Adverum Biotechnologies Inc nowJuly 2025 Intraday Action & Technical Confirmation Trade Alerts - baoquankhu1.vn
Whats the profit margin of Adverum Biotechnologies Inc2025 Volume Leaders & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Levels Update: Is Adverum Biotechnologies Inc gaining market shareMarket Sentiment Summary & Advanced Technical Signal Analysis - baoquankhu1.vn
Is Adverum Biotechnologies Inc. gaining market share2025 Valuation Update & Safe Capital Growth Plans - mfd.ru
Will Adverum Biotechnologies Inc. announce a stock split2025 Macro Impact & Risk Controlled Daily Trade Plans - mfd.ru
What is Adverum Biotechnologies Inc.’s book value per shareJuly 2025 Outlook & Reliable Trade Execution Plans - mfd.ru
What dividend growth rate does Adverum Biotechnologies Inc. offerMarket Trend Review & Verified Stock Trade Ideas - mfd.ru
What is the earnings history of Adverum Biotechnologies Inc.July 2025 Final Week & Growth Focused Stock Pick Reports - mfd.ru
Published on: 2026-02-10 18:51:18 - mfd.ru
Decliners Report: Can Adverum Biotechnologies Inc beat the S P 500Sell Signal & Weekly High Conviction Ideas - baoquankhu1.vn
Eli Lilly To Acquire Adverum Biotechnologies - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating Adverum Biote - The National Law Review
Can Adverum Biotechnologies Inc lead its sector in growthWeekly Trend Recap & Growth Focused Stock Reports - baoquankhu1.vn
Market Recap: How do insiders feel about Adverum Biotechnologies IncPortfolio Update Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Weekly Earnings: What is Adverum Biotechnologies Inc.’s book value per share2025 AllTime Highs & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Trade Report: Is ENTO a good stock for dollar cost averagingMarket Performance Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Aug Intraday: Is Adverum Biotechnologies Inc showing insider buyingTrade Analysis Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Insider Buy: What is the earnings history of Adverum Biotechnologies IncJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug EndMonth: Is Adverum Biotechnologies Inc a strong candidate for buy and holdEarnings Overview Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Adverum Biotechnologies2026 Funding Rounds & List of Investors - Tracxn
$191.2 Million Achromatopsia Market Outlook, 2026-2032, - GlobeNewswire
$191.2 Million Achromatopsia Market Outlook, 2026-2032, Featuring Adverum Biotechnologies, Homology Medicines, Mattel, REGENXBIO, Sanofi and More - Yahoo Finance
Retail Surge: What is the earnings history of Adverum Biotechnologies IncJuly 2025 Selloffs & Daily Oversold Bounce Ideas - baoquankhu1.vn
Fund Flows: Can Adverum Biotechnologies Inc stock outperform in 2025 bull marketJuly 2025 EndofMonth & Long-Term Safe Return Strategies - Bộ Nội Vụ
Wall Street Recap: Why Adverum Biotechnologies Inc stock remains undervaluedQuarterly Growth Report & Verified Short-Term Plans - Bộ Nội Vụ
Gainers Report: Why Adverum Biotechnologies Inc stock remains undervaluedMarket Risk Report & Low Risk High Reward Trade Ideas - Bộ Nội Vụ
Is Adverum Biotechnologies Inc. stock a dividend growth opportunityJuly 2025 Update & Long-Term Capital Growth Ideas - Улправда
How Adverum Biotechnologies Inc. stock benefits from strong dollarPortfolio Return Report & Real-Time Stock Entry Alerts - Улправда
Why hedge funds are buying Adverum Biotechnologies Inc. stockJuly 2025 Closing Moves & Weekly Sector Rotation Insights - Улправда
What drives Adverum Biotechnologies Inc stock priceValue Stock Picks & Capital Planning and Optimization - earlytimes.in
ADVM stock touches 52-week low at $4.01 amid market challenges - MSN
Adverum Biotechnologies, Inc. Financial Disclosures & Filings - TradingView — Track All Markets
Adverum Biotechnologies (NASDAQ:ADVM) Stock Price Passes Above 50 Day Moving Average – Time to Sell? - Defense World
Is Adverum Biotechnologies Inc. (AVU0) stock trading at attractive multiplesJuly 2025 Catalysts & Short-Term High Return Ideas - Bölüm Sonu Canavarı
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives $10.50 Average PT from Brokerages - Defense World
What catalysts could drive Adverum Biotechnologies Inc. stock higherJuly 2025 Chart Watch & Fast Momentum Entry Tips - Улправда
Why Adverum Biotechnologies Inc. stock is rated strong buyWeekly Trend Report & Free Long-Term Investment Growth Plans - DonanımHaber
Why Adverum Biotechnologies Inc. stock is in analyst buy zoneJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - DonanımHaber
Investor Mood: Why Adverum Biotechnologies Inc stock is in analyst buy zoneJuly 2025 Review & Precise Swing Trade Entry Alerts - moha.gov.vn
Adverum Biotechnologies releases promising phase 2 trial data - MSN
Adverum Biotechnologies Earnings Notes - Trefis
Adverum Biotechnologies, Inc. Stock ()Quote BOERSE BERLIN - marketscreener.com
Adverum Biotechnologies (NASDAQ:ADVM) Lowered to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Adverum Biotechnologies (NASDAQ:ADVM) Lowered to “Strong Sell” Rating by Wall Street Zen - Defense World
Finanzdaten der Adverum Biotechnologies Inc-Aktie (ADVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.28%
17.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):